Merck Animal Health (known as MSD Animal Health outside the United States and Canada) today announced that, following a positive opinion from the Committee for Medicinal Products for Veterinary Use (CVMP), the European Commission has granted the marketing authorization for the veterinary medicinal product PANACUR® AquaSol (fenbendazole 200 mg/mL) for use in chickens.
PANACUR® AquaSol is a highly stable, farm-friendly, water-administered suspension product produced with an innovative wet-milling technology. It is currently available in the EEA for use in swine.
“We are very pleased that the European Commission has approved PANACUR® AquaSol for chickens,” stated Fabio Paganini, Associate Vice President, Merck Animal Health. “PANACUR® has a long history of proven results as a leading dewormer and we are excited to bring this option for convenient water administration to chicken farmers throughout the EEA.”Approved indication:
PANACUR® AquaSol will be indicated for the treatment of gastro-intestinal nematodes in chickens infected with:
- Ascaridia galli (L5 and adult stages)
- Heterakis gallinarum (L5 and adult stages)
Through the company’s proprietary wet-milling technology, PANACUR® AquaSol is a highly stable suspension which, as a result of smaller more uniform particle size, does not require frequent agitation and provides both a high level of efficacy and convenience.
PANACUR® AquaSol has been proven safe for all types of chickens, including layers, broilers and breeders. It has a zero day withdrawal period for eggs and a six day withdrawal period for meat and offal.